0
Correspondence |

IDEAL for CCSVI Research

Jim A. Reekers, MD, PhD, EBIR
Arch Neurol. 2012;69(7):939-940. doi:10.1001/archneurol.2012.322.
Text Size: A A A
Published online

Extract

I read with great interest the editorial titled “No Endovascular Innovation Without Evaluation in Chronic Cerebrospinal Venous Insufficiency: A Call for the IDEAL Model” by Williams and Venkatesan.1 Although I very much support the IDEAL model to prevent uncontrolled dissemination of unproven or even harmful procedures, this does not mean that any sort of research can be done. The authors stated that the demand by patients with multiple sclerosis for research on endovascular interventions in chronic cerebrospinal venous insufficiency (CCSVI) is so great that any call to halt it would serve only to propel the unregulated and unmonitored off-label practice, which is likely to cause more harm than would carefully monitored clinical trials. What this actually means is that you have to tell your patient during informed consent, when you perform research for CCSVI, that you do this to prevent further unregulated off-label use, which is likely to cause harm. In article 9 of the Declaration of Helsinki, it is stated: “Medical research is subject to ethical standards that promote respect for all human subjects and protect their health and rights.” Asking patients to participate in a trial just to prevent unregulated and unmonitored off-label practice means that the researcher does not believe the CCSVI hypothesis is true. The overwhelming accumulation of high-quality papers all speaking against CCSVI in the last 2 years, some published in this journal, actually make it impossible to believe that the CCSVI hypothesis is or can be true. Medical research should only be conducted to find an answer to a research question, not to satisfy the popular voice. The original IDEAL paper also stated: “Trials are unnecessary when an advance is clear and substantial.”2 I would argue that the opposite is also true: Trials are also unnecessary when the advance is clearly unproven. Research should be conducted to challenge scientific doubt and when there is no scientific doubt, either positive or negative, any trial is unethical and should not be performed.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

July 1, 2012
Michael A. Williams, MD; Arun Venkatesan, MD, PhD
Arch Neurol. 2012;69(7):939-940. doi:10.1001/archneurol.2012.325.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
[Ethical aspects of clinical trials in patients with multiple sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova 2009;;109(7 Suppl 2):86-9.
Jobs